- Mac QD, Xu C, Bowen JR, Sivakumar A, Phuengkham H, Su FY, Stentz SZ, Sim H, Harris AM, Li TT, Qiu P, and Kwong GA, “Activity-based urinary biomarkers of response and resistance to checkpoint blockade immunotherapy” under review, bioRxiv 2020.12.10.420265 preprint.
- Bazrafshan A, Kyriazi ME, Holt BA, Deng W, Piranej S, Su H, Hu Y, El-Sagheer A, Brown T, Kwong GA, Kanaras A, and Salaita K, “RNA-fueled DNA-gold nanoparticle rolling motors travel micron distances in minutes” under revision.
- Kwong GA‡, Ghosh S, Gamboa L, Patriotis C, Srivastava S‡, and Bhatia SN‡, “Synthetic Biomarkers: A 21st century path to early cancer detection” under revision.
- Cazanave SC, Warren AD, Pacula M, Touti F, Zagorska A, Gural N, Huang EK, Sherman S, Cheema M, Ibarra S, Serer A, Bates J, Billin AN, Liles JT, Budas GR, Breckenridge DG, Tiniakos D, Ratziu V, Daly AK, Govaere O, Anstee QM, Gelrud L, Luther J, Chung RT, Corey KE, Winckler W, Bhatia SN, and Kwong GA, “Noninvasive urinary monitoring of non-alcoholic steatohepatitis by mass barcoded activity-based sensors” under revision.
- Miller IC, Sun LK, Harris AM, Gamboa L, Zamat A and Kwong GA, “Remote control of CAR T cell therapies by thermal targeting” under revision, biorxiv 062703 preprint.
- Holt BA, Curro I and Kwong GA, “Prodrug defiance reveals logic-based strategies to treat bacterial resistance” under review.
- Su FY†, Mac QD†, Sivakumar A, and Kwong GA, “Interfacing biomaterials with synthetic T cell immunity” Adv. Healthc. Mat. in press (2021).
- Dahotre SN†, Romanov A†, Su FY, and Kwong GA, “Synthetic antigen-presenting cells for adoptive T cell therapy” Adv. Thera. 2100034 (2021). [DOI: 10.1002/adtp.202100034]
- Turner TC†, Sok MCP†, Hymel LA†, Pittman F, York WY, Mac QD, Vishna S, Lim HS, Kwong GA, Qiu P, and Botchwey EA, “Harnessing lipid signaling pathways to target specialized pro-angiogenic neutrophil subsets for regenerative immunotherapy” Sci. Adv. 6(44), eaba7702 (2020). [DOI: 10.1126/sciadv.aba7702]
- Holt BA and Kwong GA, “Protease circuits for processing biological information” Nat. Commun. 11, 5021 (2020). [DOI: 10.1038/s41467-020-18840-8]
Summary | Biological circuits engineered to interface with living systems will enable new applications for programmable immune therapies and diagnostics. In this study, we explored how treating proteases as ‘biological bits’ could be used to design cell-free biocircuits with the capacity to perform digital operations such as analog-to-digital conversion for drug delivery, as well as analog operations that implement ‘fuzzy logic’ to solve mathematical problems.
Press Coverage | Georgia Tech Research Horizons “‘Programmable Medicine’ is the goal for new bio-circuitry research” | Phys.org | Mirage News | TMR Blog
- Gamboa L†, Zamat A† and Kwong GA, “Synthetic immunity by remote control” Theranostics 10(8): 3652–3667 (2020). [DOI: 10.7150/thno.41305]
- Kwong GA, “Macrophage sensors for early cancer detection” Clin. Chem. 66(2), 268–270 (2020). [DOI: 10.1093/clinchem/hvz017]
- Tadros AR, Romanyuk A, Miller IC, Santiago A, Noel RK, O’Farrell L, Kwong GA and Prausnitz MR, “STAR particles for enhanced topical drug and vaccine delivery” Nat. Med. 26, 341–347 (2020). [DOI:10.1038/s41591-020-0787-6]
- Gamboa L, Phung EV, Li H, Meyers JP, Miller IC and Kwong GA, “Heat-triggered remote control of CRISPR-dCas9 for tunable transcriptional modulation” ACS Chem. Biol. 15(2), 533–542 (2020). [DOI: 10.1021/acschembio.9b01005]
Summary | CRISPR-based approaches have achieved wide success in modulating gene activity to control cell function and are potential tools for clinical therapies. However, the lack of precise methods to deliver and control Cas protein expression in vivo remains a critical hurdle. Here we develop a tunable, heat-triggered platform that regulates mammalian cell transcription by remote control of dCas9 transcriptional modulators.
- Zhuang Q†, Holt BA†, Kwong GA‡ and Qiu P‡, “Deconvolving multiplexed protease signatures with substrate reduction and activity clustering” PLoS Comput. Biol. 15(9): e1006909 (2019). [DOI: 10.1371/journal.pcbi.1006909]
- Mac QD†, Mathews DV†, Kahla JA, Stoffers C, Delmas OM, Holt BA, Adams AB‡ and Kwong GA‡, “Non-invasive early detection of acute transplant rejection via nanosensors of granzyme B activity” Nat. Biomed. Eng. 3, 281–291 (2019). [DOI: 10.1038/s41551-019-0358-7]
Summary | The current diagnostic “gold” standard to monitor transplant patients for signs of organ rejection is the tissue biopsy. However, this procedure is invasive and lacks the ability to detect rejection at an early stage. We developed immune sensors that sense anti-graft immune activity from recipient urine, allowing noninvasive detection at the onset of transplant rejection. Press Coverage | Georgia Tech Research Horizons “Urine test detects organ transplant rejection, could replace needle biopsies” | Nature Rev Nephrology “Nanosensors enable early detection of acute T cell-mediated rejection of transplants” | Nature BME “Urinary nanosensors of early transplant rejection” | EurekAlert! “Fluorescing urine signals organ transplant rejection, could replace needle biopsies” | Medical Design and Outsourcing “How urine tests could detect organ transplant rejection and eliminate needle biopsies” | Newswise | TECHExplorist | LongRoom | The Medical News | Science Daily | Medical Xpress | GENbio | MD linx | MDedge | Medical Health News | Pediatric News | Medgadget | ECNmag | InsiderAdvantage | Wearable Technologies |
- Dahotre SN, Chang YM, Romanov AM and Kwong GA, “DNA-barcoded pMHC tetramers for detection of single antigen-specific T cells by digital PCR” Anal. Chem. 91(4), 2695–2700 (2019). [DOI: 10.1021/acs.analchem.8b04153]
- Holt BA, Mac QD and Kwong GA, “Nanosensors to detect protease activity in vivo for noninvasive diagnostics” J. Vis. Exp. (130), e37937, (2018). [DOI: 10.3791/57937]
- Miller IC, Gamboa Castro M, Maenza J, Weis JP and Kwong GA, “Remote control of mammalian cells with heat-triggered gene switches and photothermal pulse trains” ACS Synth. Biol. 7(4), 1167–1173 (2018). [DOI: 10.1021/acssynbio.7b00455]
Summary | Genetically engineered T cells have the potential to cure patients of cancer. Yet after they are infused into recipients, we lack the ability to control their activity throughout the body including at disease sites. Here we genetically engineer T cells to allow them to be remotely controlled using pulses of heat localized by laser light. This could improve the precision of T cell therapies for cancer.
Press Coverage | Georgia Tech Research Horizons “Remote-control shoots laser at nano-gold to turn on cancer-killing immune cells” | ASME “Precisely targeting tumors with cancer fighting T cells” | Medical News Today “This ‘genetic switch’ could help fight cancer” | Science Daily | Controlled Environments | Phys.org | EurekAlert! | Nanowerk | Nanotechnology Now | Medgadget “Remote-controlled signal activates T cells for cancer immunotherapy”
- Dahotre SN, Chang YM, Wieland A, Stammen SR and Kwong GA, “Individually addressable and dynamic DNA gates for multiplexed cell sorting” Proc. Natl. Acad. Sci. USA 115(17), 4357–4362 (2018). [DOI: 10.1073/pnas.1714820115]
- Dudani JS, Buss CG, Akana RTK, Kwong GA and Bhatia SN, “Sustained-release synthetic biomarkers for monitoring thrombosis and inflammation using point-of-care compatible readouts” Adv. Funct. Mater. 26(17), 2919–2928 (2016). [DOI: 10.1002/adfm.201505142]
- Dudani JS, Jain PK, Kwong GA, Stevens KR and Bhatia SN, “Photoactivated spatiotemporally-responsive nanosensors of in vivo protease activity” ACS Nano 9(12), 11708–11717 (2015). [DOI: 10.1021/acsnano.5b05946]
- Kwong GA, Dudani JS, Carrodeguas E, Mazumdar EV, Zekavat MS and Bhatia SN, “Mathematical framework for activity-based cancer biomarkers” Proc. Natl. Acad. Sci. USA 112(41), 12627–12632 (2015). [DOI: 10.1073/pnas.1506925112]
- Danino T†, Prindle A†, Kwong GA, Skalak M, Li H, Allen K, Hasty J and Bhatia SN, “Programmable probiotics for detection of cancer in urine” Sci. Transl. Med. 7(289), 289ra84 (2015). [DOI: 10.1126/scitranslmed.aaa3519]
Warren AD, Gaylord ST, Ngan KC, Milutinovic MD, Kwong GA, Bhatia SN and Walt DR, “Disease Detection by Ultrasensitive Quantification of Microdosed Synthetic Urinary Biomarkers” J. Am. Chem. Soc. 136(39), 13709–13714 (2014). [DOI: 10.1021/ja505676h]
- Lin KY, Lo JH, Consul N, Kwong GA and Bhatia SN, “Self-titrating anticoagulant nanocomplexes that restore homeostatic regulation of the coagulation cascade” ACS Nano 8(9), 8776–8785 (2014). [DOI: 10.1021/nn501129q]
- Warren AD†, Kwong GA†, Wood DK†, Lin KY and Bhatia SN, “Point-of-care diagnostics for noncommunicable diseases using synthetic urinary biomarkers and paper microfluidics” Proc. Natl. Acad. Sci. USA 1119(10), 3671–3676 (2014). [DOI: 10.1073/pnas.131465111]
Summary | Meeting global health challenges will require cheap diagnostics to be deployed in resource-limited environments. We developed low-cost paper tests for detecting diseases from urine, similar to commercial home pregnancy tests. Our test strips do not require expensive instruments, and could lead to better identification of patients with diseases in settings where access to healthcare is limited.
Press Coverage | MIT News “A paper diagnostic for cancer” | FOX News “Simple paper urine test may detect cancer, blood clots” | 90.9 wbur (Boston’s NPR) “Research explores pregnancy-type test for detecting cancer” | CNET “Pee here to find out if you have cancer” | Science News “Urine test detects not pregnancy but cancer” | Wired “Get an injection, pee on a stick, get a cancer diagnosis” | Gizmodo “New paper-based urine tests could detect cancer and heart disease” | Medical News Today “Cheap urine test for cancer steps closer” | Smart Planet “Paper test strip detects cancer in minutes” | New Scientist “Cancer diagnosis as simple as a pregnancy test”
- Lin KY†, Kwong GA†, Warren AD, Wood DK and Bhatia SN, “Nanoparticles that sense thrombin activity as synthetic biomarkers of thrombosis” ACS Nano 7(10), 9001–9009 (2013). [DOI: 10.1021/nn403550c]
Summary | Blood clots are dangerous as they can break off and lodge in small blood vessels, which can cause pulmonary embolism in the lungs or a stroke in the brain. We developed miniaturized biosensors to sense the activity of thrombin – the key enzyme involved in clot formation – that could help detect blood clots before they become an issue.
Press Coverage | MIT News “Finding blood clots before they wreak havoc” | The Economist “Particle Physiology” | Huffington Post “Test to detect hidden blood clots on the horizon” | ACS “Toward a urine test for detecting blood clots” | AzoNano “Blood clots chop peptides added onto nanomaterials” | Medical News Today “Nanotechnology urine test could detect deadly blood clots” | Health Central “Urine test could find blood clots early” | HealthLine “Simple urine test spots dangerous blood clots”
- Kwong GA, von Maltzahn G, Murugappan G, Abudayyeh O, Mo S, Papayannopoulos IA, Sverdlov D, Liu SB, Warren AD, Popov Y, Schuppan D and Bhatia SN, “Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease” Nat. Biotechnol. 31, 63–70 (2013). [DOI: 10.1038/nbt.2464]
Summary | Catching cancer at an early stage markedly improves patient prognosis, yet current blood biomarkers lack the sensitivity to indicate small tumors when they are most responsive to treatments. We pioneered the first class of nano-scale biological sensors for early cancer detection. These engineered biomarkers circulate in the body, survey for nascent tumor sites, and report on their activity by shedding detection signals into urine. This noninvasive technology could lead to earlier diagnosis and following response to treatment.
Press Coverage | MIT news “New technology may enable early cancer diagnosis” | Phys.org “Nanoparticles amplify tumor signals, making them easier to detect in the urine” | Cancer Discovery “Synthetic biomarkers identify early cancer” | FierceHealthIT “Nanotechnology enables creation of biomarkers for early cancer detection” | AZoNano “Novel nanoparticles for easier biomarker detection” | NZZ am Sonntag | Nanomedicine | Newsroom America | ProteoMonitor | National Cancer Institute
- Millward SW, Henning R, Kwong GA, Pitram S, Agnew HD, Deyle KM, Nag A, Hein J, Lee SS, Lim J, Pfeilsticker JA, Sharpless KB and Heath JR, “Iterative in situ click chemistry assembles a branched capture agent and allosteric inhibitor for Akt1” J. Am. Chem. Soc. 133, 18280–88 (2011). [DOI: 10.1021/ja2064389]
- Vermesh U†, Vermesh O†, Wang J, Kwong GA, Ma C, Hwang K and Heath JR, “High-density, multiplexed patterning of cells at single-cell resolution for tissue engineering and other applications” Angew. Chem. 50, 7378–80 (2011). [DOI: 10.1002/anie.201102249]
- Ma C, Fan R, Ahmad H, Shi Q, Comin-Anduix B, Chodon T, Koya R, Liu C, Kwong GA, Radu C, Ribas A and Heath JR, “A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells” Nat. Med. 17, 738–43 (2011). [DOI: 10.1038/nm.2375]
- Kwong GA, Radu CG, Shu J, Koya R, Comin-Anduix B, Hadrup S, Bailey RC, Witte ON, Schumacher TN, Ribas A and Heath JR, “Modular nucleic acid assembled p/MHC microarrays for multiplexed sorting of antigen-specific lymphocytes” J. Am. Chem. Soc. 131(28), 9695-703 (2009). [DOI: 10.1021/ja9006707]
- Fan R, Vermesh O, Srivastava A, Yen B, Qin L, Ahmad H, Kwong GA, Liu C, Gould J, Hood L and Heath JR, “Integrated barcode chips for rapid, multiplexed analysis of proteins in microliter quantities of blood” Nat. Biotechnol. 26(12), 1373–8 (2008). [DOI: 10.1038/nbt.1507]
- Bailey RC, Kwong GA, Radu CG, Witte ON and Heath JR, “DNA-encoded antibody libraries: a unified platform for multiplexed cell sorting and detection of genes and proteins” J. Am. Chem. Soc. 129(7), 1959–67 (2007). [DOI: 10.1021/ja065930i]
- Bunimovich Y, Shin Y, Yeo W, Amori M, Kwong GA and Heath JR, “Quantitative real-time measurements of DNA hybridization with alkylated nonoxidized silicon nanowires in electrolyte solutions” J. Am. Chem. Soc. 128(50), 16323–31 (2006). [DOI: 10.1021/ja065923u]